EFFECT OF A SUSTAINED-RELEASE FORMULATION OF DILTIAZEM ON THE DEVELOPMENT OF ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS

被引：25

作者：

DICCIANNI, MB

CARDIN, AD

BRITT, AL

JACKSON, RL

SCHWARTZ, A

机构：

[1] UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267

[2] UNIV CINCINNATI,COLL MED,DIV LAB ANIM MED,CINCINNATI,OH 45267

来源：

ATHEROSCLEROSIS | 1987年 / 65卷 / 03期

关键词：

D O I：

10.1016/0021-9150(87)90035-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：199 / 205

页数：7

共 28 条

[1]

[Anonymous], 1984, J AM MED ASS, V251, P351

[2] THERAPEUTIC EFFECT OF DILTIAZEM ON MYOCARDIAL-CELL INJURY DURING THE CALCIUM PARADOX [J].

ASHRAF, M ;

ONDA, M ;

HIROHATA, Y ;

SCHWARTZ, A .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1982, 14 (06) :323-327

[3] MECHANISM OF PROTECTION FROM ATHEROSCLEROSIS BY VERAPAMIL IN THE CHOLESTEROL-FED RABBIT [J].

BLUMLEIN, SL ;

SIEVERS, R ;

KIDD, P ;

PARMLEY, WW .

AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) :884-889

[4] CALCIUM-ANTAGONISTS AND ATHEROSCLEROSIS - BASIC STUDIES AND THERAPEUTIC IMPLICATIONS [J].

DEFEUDIS, FV .

LIFE SCIENCES, 1983, 32 (06) :557-563

[5]

FLECKENSTEIN A, 1983, NEW CALCIUM ANTAGONI, P15

[6]

GINSBURG R, 1983, LAB INVEST, V49, P154

[7] XEROGRAPHIC METHOD FOR QUANTITATIVE ASSESSMENT OF ATHEROSCLEROTIC LESIONS [J].

HATA, Y ;

SHIGEMATSU, H ;

TSUSHIMA, M ;

AIHARA, K .

ATHEROSCLEROSIS, 1978, 29 (02) :251-258

[8] SUPPRESSION OF ATHEROGENESIS IN CHOLESTEROL-FED RABBIT TREATED WITH NIFEDIPINE [J].

HENRY, PD ;

BENTLEY, KI .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1366-1369

[9] COMPARATIVE PHARMACOLOGY OF CALCIUM ANTAGONISTS - NIFEDIPINE, VERAPAMIL AND DILTIAZEM [J].

HENRY, PD .

AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (06) :1047-1058

[10] ATHEROSCLEROSIS, CALCIUM, AND CALCIUM-ANTAGONISTS [J].

HENRY, PD .

CIRCULATION, 1985, 72 (03) :456-459

← 1 2 3 →